Lorraine A. Chantrill

Author

Also Known As

A L Johns, Anthony J. Gill, Australian Pancreatic Cancer Genome Initiative (APGI), Cecilia R. Chambers, David K. Chang, Hong Ching Lee, Jeremy Humphris, L. A. Chantrill, L. Chantrill, L.A. Chantrill

119

Publications

12.4K

Citations

H-Index

Concepts

All Affiliations

The University of Sydney Royal North Shore Hospital Garvan Institute of Medical Research UNSW Sydney The Kinghorn Cancer Centre

About

Lorraine A. Chantrill is an author at The University of Sydney specializing in medicine, pathology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	4K
2	Public Health	1	1	44
3	Epidemiology	1	1	44
4	Health Informatics	1	1	27
5	Immunology	1	1	11

Lorraine A. Chantrill

Publications

5.6K

Citations

H-Index

Page 1

	Year	Citations
Genomic analyses identify molecular subtypes of pancreatic cancer Peter J. Bailey, David K. Chang, Kátia Nones, Nature Pancreatic CancerMedicinePathologyCancer GenomicsMolecular Diagnostics	2016	3.6K
The prognostic and predictive value of serum CA19.9 in pancreatic cancer Jeremy L. Humphris, David K. Chang, Amber L. Johns, Annals of Oncology	2012	290
Transient tissue priming via ROCK inhibition uncouples pancreatic cancer progression, sensitivity to chemotherapy, and metastasis Claire Vennin, Venessa Chin, Sean Warren, Science Translational Medicine	2017	262
Precision Medicine for Advanced Pancreas Cancer: The Individualized Molecular Pancreatic Cancer Therapy (IMPaCT) Trial Lorraine A. Chantrill, Adnan Nagrial, Clare Watson, Clinical Cancer Research	2015	234
Hypermutation In Pancreatic Cancer Jeremy L. Humphris, Ann‐Marie Patch, Kátia Nones, Gastroenterology Pancreatic CancerPathologyMedicineCancer ResearchTumor Biology	2016	203
Histomolecular Phenotypes and Outcome in Adenocarcinoma of the Ampulla of Vater David K. Chang, Nigel B. Jamieson, Amber L. Johns, Journal of Clinical Oncology	2013	175
Clinical and molecular characterization of HER2amplified-pancreatic cancer Angela Chou, Nicola Waddell, Mark J. Cowley, Genome Medicine	2013	117
Tailored first-line and second-line CDK4-targeting treatment combinations in mouse models of pancreatic cancer Angela Chou, Danielle Froio, Adnan Nagrial, Gut	2017	117
Atezolizumab and chemotherapy for advanced or recurrent endometrial cancer (AtTEnd): a randomised, double-blind, placebo-controlled, phase 3 trial Nicoletta Colombo, Elena Biagioli, Kenichi Harano, The Lancet Oncology Gynecological SurgeryMedicineMetronomic TherapyGynecologyRecurrent Endometrial Cancer	2024	89
Clinical and pathologic features of familial pancreatic cancer Jeremy L. Humphris, Amber L. Johns, Skye H. Simpson, Cancer	2014	63

Page 1